Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis

Simple item page
dc.contributor.authorFisher, J. H
dc.contributor.authorKolb, M.
dc.contributor.authorAlgamdi, M.
dc.contributor.authorMorisset, J.
dc.contributor.authorJohannson, K. A
dc.contributor.authorShapera, S.
dc.contributor.authorWilcox, P.
dc.contributor.authorTo, T.
dc.contributor.authorSadatsafavi, M.
dc.contributor.authorManganas, H.
dc.contributor.authorKhalil, N.
dc.contributor.authorHambly, N.
dc.contributor.authorHalayko, A. J
dc.contributor.authorGershon, A. S
dc.contributor.authorFell, C. D
dc.contributor.authorCox, G.
dc.contributor.authorRyerson, C. J
dc.date.accessioned2019-12-01T04:28:11Z
dc.date.issued2019-11-27
dc.date.updated2019-12-01T04:28:11Z
dc.description.abstractAbstract Background The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF) is a multi-center, prospective registry designed to study the natural history of fibrotic interstitial lung disease (ILD) in adults. The aim of this cross-sectional sub-study was to describe the baseline characteristics, risk factors, and comorbidities of patients enrolled in CARE-PF to date. Methods Patients completed study questionnaires and clinical measurements at enrollment and each follow-up visit. Environmental exposures were assessed by patient self-report and comorbidities by the Charlson Comorbidity Index (CCI). Baseline characteristics, exposures, and comorbidities were described for the overall study population and for incident cases, and were compared across ILD subtypes. Results The full cohort included 1285 patients with ILD (961 incident cases (74.8%)). Diagnoses included connective tissue disease-associated ILD (33.3%), idiopathic pulmonary fibrosis (IPF) (24.7%), unclassifiable ILD (22.3%), chronic hypersensitivity pneumonitis (HP) (7.5%), sarcoidosis (3.2%), non-IPF idiopathic interstitial pneumonias (3.0%, including idiopathic nonspecific interstitial pneumonia (NSIP) in 0.9%), and other ILDs (6.0%). Patient-reported exposures were most frequent amongst chronic HP, but common across all ILD subtypes. The CCI was ≤2 in 81% of patients, with a narrow distribution and range of values. Conclusions CTD-ILD, IPF, and unclassifiable ILD made up 80% of ILD diagnoses at ILD referral centers in Canada, while idiopathic NSIP was rare when adhering to recommended diagnostic criteria. CCI had a very narrow distribution across our cohort suggesting it may be a poor discriminator in assessing the impact of comorbidities on patients with ILD.
dc.identifier.citationBMC Pulmonary Medicine. 2019 Nov 27;19(1):223
dc.identifier.urihttps://doi.org/10.1186/s12890-019-0986-4
dc.identifier.urihttp://hdl.handle.net/1993/34382
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderThe Author(s).
dc.titleBaseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12890_2019_Article_986.pdf
Size:
1018.74 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works